Light Mode
$1.73 ↑ +0.03 (+1.76%) Trading Up from the previous close of $1.70
-0.02 (-1.16%) / 6M
Momentum, market sentiment, and recent alerts
CDIO reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -59.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated comorbidities, including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded by Meeshanthini V. Dogan and Robert Philibert in 2017 and is headquartered in Chicago, IL.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.